Mediators of Exercise Effects on HRQoL in Cancer Survivors after Chemotherapy
Authors:
- Joeri KalterJKJoeri Kalter
- Caroline S. KampshoffCKCaroline S. Kampshoff
- Mai J. M. ChinapawMCMai J. M. Chinapaw
- Willem VAN MechelenWMWillem VAN Mechelen
- Francisca Galindo-GarreFGFrancisca Galindo-Garre
- Goof SchepGSGoof Schep
- Irma M. Verdonck-De LeeuwILIrma M. Verdonck-De Leeuw
- Johannes BrugJBJohannes Brug
- Laurien M. BuffartLBLaurien M. Buffart
- 1 October 2016
- journal article
- Published by Wolters Kluwer Health in Medicine & Science in Sports & Exercise
- Vol. 48 (10) , 1859-1865
Abstract
We investigated the hypothesis that combined resistance and endurance exercise improves cardiorespiratory fitness and muscle strength, thereby reducing fatigue and improving global quality of life (QoL) and physical function among cancer survivors who completed curative treatment including chemotherapy. Cancer survivors were assigned to a 12-wk exercise intervention (n = 186) or a wait list control group (n = 91). Data were collected at baseline and after 12 wk. Path analyses using follow-up values adjusted for baseline values, age, and gender were conducted to test if the exercise effects on global QoL and physical function (European Organization Research and Treatment of Cancer Quality of Life questionnaire-Core 30) were mediated by changes in cardiorespiratory fitness (peak V˙O2), hand-grip strength, lower body muscle function (30-s chair stand test), and fatigue (Multidimensional Fatigue Inventory). Compared with the wait list control, exercise increased cardiorespiratory fitness (β = 1.8; 95% confidence interval (CI), 1.0–2.6 mL·kg−1·min−1) and reduced general (β = −1.0; 95% CI, −1.8 to −0.2) and physical fatigue (β = −1.5; 95% CI, −2.3 to −0.6). The exercise effect on physical fatigue was mediated by change in cardiorespiratory fitness (β = −0.2; 95% CI, −0.4 to −0.1). Higher hand-grip strength was significantly associated with lower physical fatigue and better lower body muscle function with lower physical and general fatigue. Lower general fatigue and physical fatigue were significantly associated with higher global QoL (β = −1.6; 95% CI, −2.2 to −1.1; and β = −1.7; 95% CI, −2.3 to −1.1, respectively) and physical function (β = −1.0; 95% CI, −1.3 to −0.7; and β = −1.2; 95% CI, −1.6 to −0.9, respectively). The models explained 44%–61% of the variance in global QoL and physical function. Beneficial effects of exercise on global QoL and physical function in cancer survivors were mediated by increased cardiorespiratory fitness and subsequent reductions in fatigue.Keywords
This publication has 34 references indexed in Scilit:
- The effect, moderators, and mediators of resistance and aerobic exercise on health‐related quality of life in older long‐term survivors of prostate cancerCancer, 2015
- Mediators of physical exercise for improvement in cancer survivors' quality of lifePsycho-Oncology, 2013
- Mediators of the resistance and aerobic exercise intervention effect on physical and general health in men undergoing androgen deprivation therapy for prostate cancerCancer, 2013
- Self-Reported Physical Activity: Its Correlates and Relationship with Health-Related Quality of Life in a Large Cohort of Colorectal Cancer SurvivorsPLOS ONE, 2012
- Clinician’s Guide to Cardiopulmonary Exercise Testing in AdultsCirculation, 2010
- Changes in Physical Functioning in the Active Living Every Day Program of the Active for Life Initiative®International Journal of Behavioral Medicine, 2010
- A population‐based study of the impact of specific symptoms on quality of life in women with breast cancer 1 year after diagnosisCancer, 2006
- Mediational Analysis in HIV/AIDS Research: Estimating Multivariate Path Analytic Models in a Structural Equation Modeling FrameworkAIDS and Behavior, 2006
- Hand-grip dynamometry provides a valid indication of upper extremity strength impairment in home care patientsJournal of Hand Therapy, 1998
- The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in OncologyJNCI: Journal of the National Cancer Institute, 1993